Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:55 PM
Ignite Modification Date:
2025-12-24 @ 9:55 PM
NCT ID:
NCT05008432
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Diagnosis of HFpEF by catheterization with resting PCWP\>15 mmHg or exercise PCWP\>25 mmHg or hospitalization with HFpEF
* Ambulatory (not wheelchair/scooter dependent)
* If no known diagnosis of OSA, must not be pacemaker dependent with either atrial pacing or VVI without sinus rhythm
* If no known diagnosis of OSA, must be able to temporarily hold nitrates or alpha channel blockers for home WatchPAT testing (3 hour washout period)
Exclusion Criteria:
* Ejection fraction \<40%
* Obstructive hypertrophic cardiomyopathy
* Constrictive pericarditis or tamponade
* Active myocarditis
* Complex congenital heart disease
* Other valve disease requiring surgical intervention
* Terminal illness (other than HF) with expected survival of less than 1 year
* Inability to comply with planned study procedures
* Pregnancy or breastfeeding mothers
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT05008432
Study Brief:
Protocol Section:
NCT05008432